[Role of synovial inflammation, cytokines and IGF-1 in the physiopathology of [PMID: 7858605] Laboratory literature summary: [Role of synovial inflammation, cytokines and IGF-1 in the physiopathology of osteoarthritis]
When GLP-1 binds to these receptors, it can shift macrophages from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype, inhibit the production of pro-inflammatory cytokines like TNF-, IL-1, and IL-6, increase anti-inflammatory adiponectin, and inhibit NF-B, a key regulator of pro-inflammatory gene expression
GLP-1 medications work through several synergistic pathways: Reduced hunger and fewer cravings make portion control feel effortless
It means the product cannot even accomplish its most basic function
These people are not recommended by the FDA to take GLP-1 medications